Hemophilia More Prevalent Than Previously Estimated
|
By HospiMedica International staff writers Posted on 01 Oct 2019 |
A new study reveals that over 1,125,000 men around the world have inherited hemophilia, three times more than previously estimated.
Researchers at McMaster University (Hamilton, ON, Canada), the World Federation of Hemophilia (WFH; Montréal, Canada), and other institutions conducted a random-effects meta-analysis of registry data from Australia, Canada, France, Italy, New Zealand, and the United Kingdom in order to estimate the prevalence and prevalence at birth of male patients with hemophilia A or B in proportion to total male population, life expectancy disadvantage as related to prevalence at birth, and the expected number of patients worldwide.
The results revealed a prevalence of hemophilia A of 17.1 cases per 100,000 males for all severities of hemophilia, six cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, five cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage (in high-income countries) is thus 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The study was published on September 10, 2019, in Annals of Internal Medicine.
“The expected number of patients with hemophilia worldwide is 1,125,000, of whom 418,000 should have severe hemophilia,” said lead author Professor Alfonso Iorio, MD, PhD, director of the Hamilton-Niagara hemophilia program at McMaster University. “Knowing how many patients are out there will enable health care systems to estimate the resources needed to treat the disease, and enable drug manufacturers to increase the investment in research to match the demand of a patient population three times larger than we previously thought.”
Hemophilia, which is found almost only in men, is caused by a genetic defect. The most common type is hemophilia A, due to a lack of clotting factor VIII. Hemophilia B, which is less common, is caused by a lack in factor IX. Hemophilia is currently treated with infusions of the missing factors to prevent or stop debilitating bleeds, but treatment is expensive and scarce in many countries. Lack of treatment leads to chronic, disabling joint disease, while bleeding into organs and brain hemorrhages can lead to disability and death.
Related Links:
McMaster University
World Federation of Hemophilia
Researchers at McMaster University (Hamilton, ON, Canada), the World Federation of Hemophilia (WFH; Montréal, Canada), and other institutions conducted a random-effects meta-analysis of registry data from Australia, Canada, France, Italy, New Zealand, and the United Kingdom in order to estimate the prevalence and prevalence at birth of male patients with hemophilia A or B in proportion to total male population, life expectancy disadvantage as related to prevalence at birth, and the expected number of patients worldwide.
The results revealed a prevalence of hemophilia A of 17.1 cases per 100,000 males for all severities of hemophilia, six cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, five cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage (in high-income countries) is thus 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The study was published on September 10, 2019, in Annals of Internal Medicine.
“The expected number of patients with hemophilia worldwide is 1,125,000, of whom 418,000 should have severe hemophilia,” said lead author Professor Alfonso Iorio, MD, PhD, director of the Hamilton-Niagara hemophilia program at McMaster University. “Knowing how many patients are out there will enable health care systems to estimate the resources needed to treat the disease, and enable drug manufacturers to increase the investment in research to match the demand of a patient population three times larger than we previously thought.”
Hemophilia, which is found almost only in men, is caused by a genetic defect. The most common type is hemophilia A, due to a lack of clotting factor VIII. Hemophilia B, which is less common, is caused by a lack in factor IX. Hemophilia is currently treated with infusions of the missing factors to prevent or stop debilitating bleeds, but treatment is expensive and scarce in many countries. Lack of treatment leads to chronic, disabling joint disease, while bleeding into organs and brain hemorrhages can lead to disability and death.
Related Links:
McMaster University
World Federation of Hemophilia
Latest Critical Care News
- AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality
- Inhaled Therapy Uses Modified Bacteria to Break Down Pseudomonas Biofilms
- Miniature Wearable Sensor Enables Continuous Cuffless Blood Pressure Monitoring
- Studies Support AI-ECG for Detecting Suspected Hypertrophic Cardiomyopathy
- Updated Staging System Standardizes Cardiogenic Shock Assessment
- Moldable Sensor Could Support Neck Muscle Monitoring and Rehabilitation
- Routine Opt-Out Screening Helps Increase Detection of Adolescent STIs
- Personalized fMRI-Guided TMS May Improve Severe OCD Symptoms
- Ultrasound Implant Could Help Monitor Spinal Cord Recovery After Surgery
- Paper-Based Patch Integrates Sweat Sensors and Drug-Delivery Microneedles
- Circuit-Free Smart Patch Uses Smartphone Camera to Monitor Pulse and Vessel Stiffness

- Chest Digital Twin Guides Light Therapy Dosing for Pneumonia
- Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery
- Wirelessly Powered Implant Targets Excess Glucose in the Blood
- Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients
- U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation
Channels
Artificial Intelligence
view channel
AI Analysis of Smartwatch ECGs May Help Detect Weakened Heart Function
Left ventricular systolic dysfunction (LVSD) occurs when the heart’s main pumping chamber does not contract effectively. The condition can remain asymptomatic for some time but may progress to symptomatic... Read more
AI Tool Speeds Echocardiogram Reporting With Comparable Accuracy
Echocardiography is the most widely used form of cardiac imaging, playing a key role in diagnosing heart disease and guiding treatment decisions. However, reviewing ultrasound images and documenting cardiac... Read moreSurgical Techniques
view channel
FDA Authorizes Robotic System for En Bloc Bladder Resection
Bladder cancer frequently recurs, making accurate staging essential for treatment planning. Conventional transurethral resection can fragment tumors, complicating margin assessment and detrusor muscle... Read more
Fluorescence Imaging Reveals Nerves Under Normal Operating-Room Lighting
Preventing unintended nerve injury remains a major concern during surgery, particularly in complex anatomical regions where nerves can be difficult to distinguish from surrounding tissue.... Read more
Programmable Microwave Ablation System Gains CE Mark for Minimally Invasive Tissue Ablation
Hospitals continue to seek minimally invasive approaches that simplify procedural planning and provide controlled energy delivery for tissue ablation. Thermal ablation systems are used across multiple... Read more
Minimally Invasive Balloon Procedure May Redirect Blood Flow During Cardiac Arrest
Out-of-hospital cardiac arrest has a low survival rate, and patients who do not respond to prolonged advanced resuscitation have few remaining treatment options. During cardiopulmonary resuscitation, blood... Read morePatient Care
view channelVirtual Reality Program May Reduce Anxiety Before Pediatric Surgery
Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read moreMedical Imaging
view channel
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more
MRI Test Identifies Candidates for Lower-Dose Radiotherapy in HPV Throat Cancer
Human papillomavirus (HPV)-positive oropharyngeal cancer is a throat cancer linked to HPV infection. Its incidence is rising, and many patients receive high-dose radiotherapy that can cause long-term swallowing... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier
Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read moreBusiness
view channel
Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings
Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more







